000			02301 a2200661 4500
005			20250514183648.0
264		0	_c20040511
008			200405s 0 0 eng d
022			_a0009-9236
024	7		_a10.1016/j.clpt.2003.12.013 _2doi
040			_aNLM _beng _cNLM
100	1		_aTaburet, Anne-Marie
245	0	0	_aInteractions between amprenavir and the lopinavir-ritonavir combination in heavily pretreated patients infected with human immunodeficiency virus. _h[electronic resource]
260			_bClinical pharmacology and therapeutics _cApr 2004
300			_a310-23 p. _bdigital
500			_aPublication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650	0	4	_aAdministration, Oral
650	0	4	_aAdult
650	0	4	_aAntiretroviral Therapy, Highly Active
650	0	4	_aBiological Availability
650	0	4	_aCarbamates
650	0	4	_aDose-Response Relationship, Drug
650	0	4	_aDrug Administration Schedule
650	0	4	_aDrug Interactions
650	0	4	_aDrug Therapy, Combination
650	0	4	_aFemale
650	0	4	_aFollow-Up Studies
650	0	4	_aFurans
650	0	4	_aHIV Infections _xdiagnosis
650	0	4	_aHumans
650	0	4	_aLopinavir
650	0	4	_aMale
650	0	4	_aMaximum Tolerated Dose
650	0	4	_aMiddle Aged
650	0	4	_aProbability
650	0	4	_aPyrimidinones _xadministration & dosage
650	0	4	_aRisk Assessment
650	0	4	_aRitonavir _xadministration & dosage
650	0	4	_aSalvage Therapy
650	0	4	_aSeverity of Illness Index
650	0	4	_aSingle-Blind Method
650	0	4	_aStatistics, Nonparametric
650	0	4	_aSulfonamides _xadministration & dosage
650	0	4	_aSurvival Rate
650	0	4	_aTreatment Outcome
650	0	4	_aViral Load
700	1		_aRaguin, Gilles
700	1		_aLe Tiec, Clotilde
700	1		_aDroz, Cécile
700	1		_aBarrail, Aurélie
700	1		_aVincent, Isabelle
700	1		_aMorand-Joubert, Laurence
700	1		_aChêne, Geneviève
700	1		_aClavel, François
700	1		_aGirard, Pierre-Marie
773	0		_tClinical pharmacology and therapeutics _gvol. 75 _gno. 4 _gp. 310-23
856	4	0	_uhttps://doi.org/10.1016/j.clpt.2003.12.013 _zAvailable from publisher's website
999			_c14776424 _d14776424